![David Krempa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Krempa
Corporate Officer/Principal bei
ETON PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
David C.
Krempa is currently Chief Business Officer at Eton Pharmaceuticals, Inc. since 2023.
Formerly, Mr. Krempa worked at Akorn, Inc. as Head-Business Development, at Sagent Pharmaceuticals, Inc. as Head-Business Development, and at Morningstar, Inc. (Research) as Equity Analyst from 2014 to 2015.
Mr. Krempa completed undergraduate studies at DePaul University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.08.2026 | 37’025 ( 0.14% ) | 2 Mio $ | 31.07.2026 |
Aktive Positionen von David Krempa
| Unternehmen | Position | Beginn |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2023 |
Ehemalige bekannte Positionen von David Krempa
| Unternehmen | Position | Ende |
|---|---|---|
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Provides investment research | Analyst-Equity | 01.03.2015 |
| SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| AKORN, INC. | Corporate Officer/Principal | - |
Ausbildung von David Krempa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Provides investment research | Finance |
Eton Pharmaceuticals, Inc.
 Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
